Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aichi Gakuin University
• Treatments: Pitavastatin

Criteria

Inclusion Criteria:

• Hypercholesterolemic patients

Exclusion Criteria:

• Patients receiving lipid-lowering agents

• Familial hypercholesterolemia

• Renal disease

• Diseases of liver, gallbladder and bile ducts

• Pregnant women